ARG’s leadership team is on a mission: partner with agile and emerging biopharma companies to realize important therapeutic goals.
They are supported by an engaged Board of Advisors as well as ARG’s invaluable Scientific Advisory Board (SAB).
“We believe helping biopharmaceutical innovations reach people with unmet medical needs is one of the great opportunities of our time.”
Paul Bishop is Chief Executive Officer of Atlantic Research Group, one of the fastest-growing and most successful CROs dedicated to small and emerging biopharmaceutical concerns. Paul, with his co-founder Lyle Camblos, has led ARG to 10 years of record sales and customer growth.
Prior to co-founding ARG, Paul served in various management roles at a large global CRO, where he specialized in project and functional management for small biotech projects. His professional experience includes oncological, immunological, metabolic disease and ophthalmological development programs both in project management and business development.
Before that, Paul held clinical development positions and participated in academic research at the University of Virginia.
Paul received his Bachelors of Arts in Biology from the University of Virginia.
“ARG is at its core dedicated to unique, innovative, and responsive relationships with clients. Our people are builders: we use our experience, technology, and corporate system as tools to make successful clinical trials.”
Lyle Camblos is President of Atlantic Research Group, and serves as President of the Board of Directors of Pharmaceutical Service Network. In this role, Lyle manages finance and overall operations while mentoring team members on project management and clinical trial execution. He is the architect of ARG’s corporate business framework, developing procedures and processes to manage explosive growth while providing a guiding hand to ensure the company retains the welcoming and supportive atmosphere of an agile small business.
Prior to co-founding Atlantic Research Group, Lyle held positions in the clinical research industry, as varied as entry-level site management to clinical research associate and project manager: his career achievements include leadership roles in mid-sized and large multinational CROs.
Lyle’s clinical research expertise extends from novel agents in orphan status phase I trials to post-marketing safety, surveillance, and oversight, including some of the largest and most successful supportive care and chemotherapeutic products on the market today. His knowledge beyond oncology includes plasma derivatives, endocrinology, immunology, and inflammatory disease indications.
Lyle earned his Bachelor of Arts in Economics at the Virginia Military Institute.
“Our team at ARG will focus on accelerating the number and sophistication of surgical studies to bring new technologies to market and new solutions to patients.”
Dr. Jeff Lawson is Chief Medical Officer at Atlantic Research Group, responsible for providing executive and medical leadership for all clinical studies, and specifically in interventional and surgical areas.
His vision is for ARG to be the best place to plan, execute and manage interventional and surgical studies, complete with the best team ready to serve new and existing sponsors, all with the goal to assist in underserved areas of medicine. Jeff brings extensive expertise in protocol design, operative proctoring, post procedure events, data collection and interventional adverse events.
He serves as adjunct professor of Surgery and Pathology at Duke University, where he has also previously acted as Vice Chair of Research, overseeing all Duke surgery clinical research and over 400 studies. He was previously CEO of both Humacyte (HUMA:Nasdaq) and InnAVasc (recently acquired by W.L. Gore) and currently a Board Member of the Kidney Health Initiative (KHI). Jeff was trained in vascular surgery and general surgery at Duke University School of Medicine, earned both an MD and PhD (Cellular and Molecular Biology) at University of Vermont, and earned a BS in Biology at the University of Iowa.
“I remember building applications in days that enabled researchers and sponsors to see exactly how their studies were doing. They were astonished at how that much data could be easily at their fingertips. That reaction is what drives me to continuously improve ARG’s technology.”
Hunter Walker is Atlantic Research Group’s Chief Technology Officer and is responsible for all clinical data management, safety, and data integration and analytics systems. Hunter’s team manages and deploys the software-as-a-service (SaaS) applications upon which all corporate operations run. Prior to joining ARG, Hunter served as a clinical technology developer with a large CRO and a small biotechnology company in San Diego. An early adopter of cloud-based technologies, Hunter constantly evaluates and implements SaaS platforms to improve the management of clinical trials.
Hunter graduated from the University of Virginia with a bachelor’s degree in Biology and an M.S. in Management of Information Technology.
Hunter’s early career as a technology expert at a clinical research organization helped him see unique opportunities for cloud-based technology to bring powerful insights to all stakeholders in the clinical trial process.
“Being part of a team of dynamic professionals that care about the work as well as each other makes my role at ARG rewarding.”
Mike Enright is Chief Financial Officer at Atlantic Research Group, responsible for providing financial leadership to help the company meet its long-term growth objectives. Mike believes that the company is well-positioned to be a global leader in the focused therapeutic areas in which we operate. Today’s environment is not something previously encountered, but it provides unique opportunities to those companies like ARG that remain nimble enough to pivot and meet changing sponsor needs.
Mike, having served over 25 years in financial leadership positions in the pharmaceutical and biotech industry, has previously held CFO roles at Biomarck Pharmaceuticals and Ockham Oncology.
Mike earned an MBA from the Kenan Flagler School of Business at the University of North Carolina at Chapel Hill, and a BS in Finance from Villanova University.
“Seeing a molecule or even an idea go from inception to drug approval and playing a small part is an amazing feeling.”
Mike Baker is Senior Vice-President of Business Development at Atlantic Research Group, responsible for leading global business strategies, initiatives, and actions in lead generation, sales, marketing, and proposals. Mike is dedicated to creating awareness throughout the world of the accomplishments of ARG, acting as the organization’s voice in educating sponsors, partners, and stakeholders about ARG, and helping sponsors advance their clinical programs and objectives.
Mike, with over 20 years of experience in the pharmaceutical and biotech industry, has participated in the process of bringing numerous drugs to the market. He has previously held leadership roles at Medsource, Covance, Chiltern, Ockham, and ASG, Inc.
Mike earned a BA in Communication from Lynchburg College.
“I really enjoy motivating and mentoring others, as well as learning from shared ideas and experiences. It’s rewarding when innovation comes to fruition and impacts others in a positive way.”
Erin Farris is Vice-President of Operations at Atlantic Research Group, responsible for overseeing Project Management, Clinical Operations, and Medical Monitoring services. Erin, along with her leadership team, provides the training and infrastructure (tools, systems, processes) necessary for individual contributors to be successful in performing the tasks at hand.
Erin looks forward to implementing an efficient and streamlined approach to risk-based quality management using robust data analytics to help project teams make informed decisions. Erin’s clinical research career started at the site level, where she was responsible for managing investigator-initiated and cooperative studies.
Always looking to understand how the pieces fit together and how to improve processes led her into project management. Erin holds a BS in Biology with a minor in Chemistry from Virginia Tech.
“Inspired by the perseverance of cancer patients, I want to help develop new therapeutic agents --moving from laboratory discovery into clinical trials as quickly and efficiently as possible--so that families have more days together, as well as greater chances for cures.”
Dr. Victoria Allgood, Vice-President, Scientific Affairs, Oncology, is responsible for collaborating with ARG’s oncology sponsors, particularly small and emerging biotech and pharma companies, to develop expedited clinical development strategies for turning their new molecules into therapeutic agents. In addition, Victoria is charged with working with her colleagues at ARG to develop and operationalize and provide oversight for clinical trials on behalf of our industry partners.
Victoria’s vision for oncology at ARG is to apply the valuable experience and expertise of the team to bring more trials to more patients in order to arrive at better treatment options.
Victoria was trained as a laboratory scientist focused on identifying new ways to diagnose, target and treat diseases, but discovered her real passion is moving laboratory discoveries into clinical trials. Previously, she has worked in the biotech and pharmaceutical industry, in academia at The University of Texas M.D. Anderson Cancer Center, and has held leadership roles in mid-size and large multinational CROs. Victoria holds both a B.S. in Chemistry and a Ph.D. in Physiology from the University of North Carolina at Chapel Hill.
“My new role will be challenging but extremely exciting, allowing me to use all my previous expertise and knowledge to put me at the forefront of developing ARG in Europe.”
Dr. Ignazio Di Giovanna, ARG Vice-President of Europe, has deep experience in the clinical research domain, having worked in the CRO field since 1990 and the pharmaceutical industry as a whole since 1986. Previously, Ignazio owned and operated the European CRO CCA Clinical Research, from 1999 until its acquisition by ARG in 2018.
Ignazio was a board member at the Institute of Clinical Research (1999-2006) and Chair from 2004 – 2006. Ignazio is past-President of the Clinical & Contract Research Association (CCRA) and a member of the Biotechnology & Pharmaceuticals Sector Advisory Group (BPSAG), advising and influencing UKTI on trade and investment matters for the sector to help improve the UK market.
Ignazio was co-editor of “Principles in Clinical Research,” published in 2001, and in April 2004 was awarded an Honorary Fellowship by the Institute of Clinical Research. Ignazio earned a PhD in Biophysics at Guys Hospital, based on the development of non-invasive cardiovascular diagnosis techniques.
“Patients who consent to a clinical trial are putting their trust in us. They deserve to have someone focused on their safety every step of the way.”
Dr. Jennifer Prichard is Medical Director at ARG, responsible for providing medical expertise and supervision for all aspects of clinical trials, from protocol development through final CSR. She provides oversight of subject safety and trial data integrity. Jen’s vision for her role moving forward is increased involvement earlier in the clinical trial process–to offer strategic advice on protocol development. In addition, she will continue to integrate sound medical and scientific knowledge in a cross-functional way so that all ARG team members are as informed as possible and can provide sponsors and sites the highest-quality of service. Jen practiced small-town, general pediatrics for five years before transitioning to the clinical trial industry in 2015. She also took time out of her career to raise four children. Jen holds an MD from Medical College of Georgia in Augusta, and completed her residency in General Pediatrics at the University of Virginia.
“I love connecting people across functional areas and geographic locations –ensuring we have one global culture and people strategy.”
Stephanie Reese is Senior Human Resources Director at Atlantic Research Group, responsible for hiring top talent, engaging and retaining employees, ensuring competitive benefits and compensation, leveraging people analytics, managing performance, overseeing office and administrative tasks, and processing payroll.
As global head of Human Resources, she wants ARG to be a premier, coveted destination where clinical trial professionals feel like family and can take advantage of a myriad of opportunities. Looking forward, Stephanie envisions partnering with the Business Intelligence team to better use data in decision-making, and with the Information Technology group to connect different systems and platforms.
She has held two previous HR positions in global technology-focused organizations and is certified via Professionals in Human Resources (PHR) and the Society for Human Resource Management(SHRM).
Stephanie earned a BS in Psychology from Radford University.
“Knowing that someone is waiting patiently for a new therapy to ease their suffering is what drives my passion to ensure that quality comes first.”
Jen Stanislawski is Director of Quality Assurance at Atlantic Research Group, responsible for overseeing the planning, coordination, management, risk assessment, and evaluation of all quality assurance activities, including coordination and integration with all functional areas.
Jen’s goals are to continually promote and communicate a culture of quality within the organization, emphasize that QA exists first and foremost to provide assistance and guidance in clinical research, and to foster the idea that all stakeholders “are in this together.” Jen has served in the healthcare industry for 25 years, including 12 years as a clinical laboratory scientist for Pfizer working on both preclinical and clinical studies, and four years at MD Anderson Cancer Center working in their Good Laboratory Practice (GLP) facility on preclinical studies.
Jen has earned the following degrees: an MSJ with a dual concentration in Pharmaceutical and Medical Device Law & Compliance and Intellectual Property from Seton Hall University, an MS in Regulatory Affairs for Drugs, Biologics, and Medical Devices from Northeastern University, and a BS in Clinical Laboratory Science from Wayne State University.
You're in great hands with ARG.
Tell us about your current or future study.